Neuropeptide FF Modulates Neuroendocrine and Energy Homeostasis through Hypothalamic Signaling

10.4103/CJP.CJP_23_19

Ya-Tin Lin；Jin-Chung Chen

Anxiety ； depression ； energy homeostasis ； food intake ； hypothalamic-pituitary-adrenal axis ； hypothalamus ； neuroendocrine ； neuropeptide FF ； neuropeptide FF receptor 2 ； obesity ； paraventricular nucleus ； thermogenesis

The Chinese Journal of Physiology

62卷2期（2019 / 04 / 30）

47 - 52

英文

Neuropeptide FF (NPFF) is known as a morphine-modulating peptide and was first isolated in 1985. It has been characterized as an RF-amide peptide. The traditional role of NPFF is mediation of the pain response, and it displays both anti-opioid and pro-opioid actions through central nervous system. In the recent decade, additional evidence has revealed some untraditional features of NPFF, such as regulation of the neuroendocrine system, energy homeostasis, anti-inflammation, pain transmission, and peripheral modulation of adipose tissue macrophages. Neuropeptide FF receptor 2 (NPFFR2) is a physiological receptor of NPFF, and the actions of NPFF may occur through downstream NPFFR2 signaling. NPFF and NPFFR2 increase the neuronal activity in various areas of the hypothalamus to modulate the hypothalamic–pituitary–adrenal axis, the autonomic nervous system, food intake, and energy balance. These underlying cellular mechanisms have been explored in the past few years. Here, we review the impact of NPFF and related RF-amide peptides on hypothalamic function. The interaction of NPFF with NPFFR2 in the hypothalamus is emphasized, and NPFF-NPFFR2 system may represent an important therapeutic target in hypothalamic-related disorders in the future.

1. Allard, M,Rousselot, P,Lombard, MC,Theodosis, DT(1999).Evidence for neuropeptide FF (FLFQRFamide) in rat dorsal root ganglia.Peptides,20,327-333.
2. Arima, H,Murase, T,Kondo, K,Iwasaki, Y,Oiso, Y(1996).Centrally administered neuropeptide FF inhibits arginine vasopressin release in conscious rats.Endocrinology,137,1523-1529.
3. Ayachi, S,Simonin, F(2014).Involvement of mammalian RF-amide peptides and their receptors in the modulation of nociception in rodents.Front Endocrinol,5,158.
4. Bechtold, DA,Luckman, SM(2006).Prolactin-releasing peptide mediates cholecystokinin-induced satiety in mice.Endocrinology,147,4723-4729.
5. Bechtold, DA,Luckman, SM(2007).The role of RFamide peptides in feeding.J Endocrinol,192,3-15.
6. Bonfiglio, JJ,Inda, C,Refojo, D,Holsboer, F,Arzt, E,Silberstein, S(2011).The corticotropin-releasing hormone network and the hypothalamic-pituitary-adrenal axis: Molecular and cellular mechanisms involved.Neuroendocrinology,94,12-20.
7. Bonini, JA,Jones, KA,Adham, N,Forray, C,Artymyshyn, R,Durkin, MM(2000).Identification and characterization of two G protein‑coupled receptors for neuropeptide FF.J Biol Chem,275,39324-39331.
8. Bray, L,Froment, C,Pardo, P,Candotto, C,Burlet-Schiltz, O,Zajac, JM(2014).Identification and functional characterization of the phosphorylation sites of the neuropeptide FF2 receptor.J Biol Chem,289,33754-33766.
9. Carrasco, GA,Van de Kar, LD.(2003).Neuroendocrine pharmacology of stress.Eur J Pharmacol,463,235-272.
10. Cline, MA,Nandar, W,Rogers, JO(2007).Central neuropeptide FF reduces feed consumption and affects hypothalamic chemistry in chicks.Neuropeptides,41,433-439.
11. Csabafi, K,Jászberényi, M,Bagosi, Z,Lipták, N,Telegdy, G.(2013).Effects of kisspeptin-13 on the hypothalamic-pituitary-adrenal axis, thermoregulation, anxiety and locomotor activity in rats.Behav Brain Res,241,56-61.
12. Dodd, GT,Worth, AA,Nunn, N,Korpal, AK,Bechtold, DA,Allison, MB(2014).The thermogenic effect of leptin is dependent on a distinct population of prolactin-releasing peptide neurons in the dorsomedial hypothalamus.Cell Metab,20,639-649.
13. Elhabazi, K,Humbert, JP,Bertin, I,Schmitt, M,Bihel, F,Bourguignon, JJ(2013).Endogenous mammalian RF-amide peptides, including prRP, kisspeptin and 26RFa, modulate nociception and morphine analgesia via NPFF receptors.Neuropharmacology,75,164-171.
14. Elshourbagy, NA,Ames, RS,Fitzgerald, LR,Foley, JJ,Chambers, JK,Szekeres, PG(2000).Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor.J Biol Chem,275,25965-25971.
15. Engström, M,Brandt, A,Wurster, S,Savola, JM,Panula, P(2003).Prolactin releasing peptide has high affinity and efficacy at neuropeptide FF2 receptors.J Pharmacol Exp Ther,305,825-832.
16. Findeisen, M,Rathmann, D,Beck-sickinger, AG(2011).Rfamide peptides: Structure, function, mechanisms and pharmaceutical potential.Pharmaceuticals,4,1248-1280.
17. Fukusumi, S,Fujii, R,Hinuma, S(2006).Recent advances in mammalian RFamide peptides: The discovery and functional analyses of PrRP, RFRPs and QRFP.Peptides,27,1073-1086.
18. Gainer, H,Yamashita, M,Fields, RL,House, SB,Rusnak, M(2002).The magnocellular neuronal phenotype: Cell‑specific gene expression in the hypothalamo-neurohypophysial system.Prog Brain Res,139,1-14.
19. Goncharuk, VD,Buijs, RM,Jhamandas, JH,Swaab, DF(2014).The hypothalamic neuropeptide FF network is impaired in hypertensive patients.Brain Behav,4,453-467.
20. Goncharuk, VD,Buijs, RM,Mactavish, D,Jhamandas, JH(2006).Neuropeptide FF distribution in the human and rat forebrain: A comparative immunohistochemical study.J Comp Neurol,496,572-593.
21. Gouardères, C,Faura, CC,Zajac, JM(2004).Rodent strain differences in the NPFF1 and NPFF2 receptor distribution and density in the central nervous system.Brain Res,1014,61-70.
22. Gouardères, C,Puget, A,Zajac, JM(2004).Detailed distribution of neuropeptide FF receptors (NPFF1 and NPFF2) in the rat, mouse, octodon, rabbit, guinea pig, and marmoset monkey brains: A comparative autoradiographic study.Synapse,51,249-269.
23. Gouardères, C,Roumy, M,Advokat, C,Jhamandas, K,Zajac, JM(2000).Dual localization of neuropeptide FF receptors in the rat dorsal horn.Synapse,35,45-52.
24. Herman, JP,Cullinan, WE,Ziegler, DR,Tasker, JG(2002).Role of the paraventricular nucleus microenvironment in stress integration.Eur J Neurosci,16,381-385.
25. Hinuma, S,Shintani, Y,Fukusumi, S,Iijima, N,Matsumoto, Y,Hosoya, M(2000).New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals.Nat Cell Biol,2,703-708.
26. Holsboer, F(2000).The corticosteroid receptor hypothesis of depression.Neuropsychopharmacology,23,477-501.
27. Jászberényi, M,Bagosi, Z,Csabafi, K,Palotai, M,Telegdy, G(2014).The actions of neuropeptide SF on the hypothalamic-pituitary-adrenal axis and behavior in rats.Regul Pept,188,46-51.
28. Jászberényi, M,Bagosi, Z,Thurzó, B,Földesi, I,Szabó, G,Telegdy, G(2009).Endocrine, behavioral and autonomic effects of neuropeptide AF.Horm Behav,56,24-34.
29. Jhamandas, JH,Goncharuk, V(2013).Role of neuropeptide FF in central cardiovascular and neuroendocrine regulation.Front Endocrinol,4,8.
30. Jhamandas, JH,MacTavish, D(2003).Central administration of neuropeptide FF causes activation of oxytocin paraventricular hypothalamic neurones that project to the brainstem.J Neuroendocrinol,15,24-32.
31. Jhamandas, JH,MacTavish, D,Harris, KH(2006).Neuropeptide FF (NPFF) control of magnocellular neurosecretory cells of the rat hypothalamic paraventricular nucleus (PVN).Peptides,27,973-979.
32. Jhamandas, JH,Simonin, F,Bourguignon, JJ,Harris, KH(2007).Neuropeptide FF and neuropeptide VF inhibit GABAergic neurotransmission in parvocellular neurons of the rat hypothalamic paraventricular nucleus.Am J Physiol Regul Integr Comp Physiol,292,R1872-R1880.
33. Kandel, ER,Schwartz, JH,Jessell, TM(2000).Principles of Neural Science.New York:McGraw-Hill, Health Professions Division.
34. Kim, JS,Brownjohn, PW,Dyer, BS,Beltramo, M,Walker, CS,Hay, DL(2015).Anxiogenic and stressor effects of the hypothalamic neuropeptide RFRP-3 are overcome by the NPFFR antagonist GJ14.Endocrinology,156,4152-4162.
35. Kivipelto, L.(1991).Ultrastructural localization of neuropeptide FF, a new neuropeptide in the brain and pituitary of rats.Regul Pept,34,211-224.
36. Kotlinska, J,PachutaA,Bochenski, M,Silberring, J(2009).Dansyl-PQRamide, a putative antagonist of NPFF receptors, reduces anxiety-like behavior of ethanol withdrawal in a plus-maze test in rats.Peptides,30,1165-1172.
37. Kotlinska, JH,Gibula-Bruzda, E,Koltunowska, D,Raoof, H,Suder, P,Silberring, J(2012).Modulation of neuropeptide FF (NPFF) receptors influences the expression of amphetamine‑induced conditioned place preference and amphetamine withdrawal anxiety-like behavior in rats.Peptides,33,156-163.
38. Lawrence, CB,Celsi, F,Brennand, J,Luckman, SM(2000).Alternative role for prolactin-releasing peptide in the regulation of food intake.Nat Neurosci,3,645-646.
39. Li, N,Han, ZL,Fang, Q,Wang, ZL,Tang, HZ,Ren, H(2012).Neuropeptide FF and related peptides attenuates warm-, but not cold-water swim stress-induced analgesia in mice.Behav Brain Res,233,428-433.
40. Lin, YT,Liu, HL,Day, YJ,Chang, CC,Hsu, PH,Chen, JC(2017).Activation of NPFFR2 leads to hyperalgesia through the spinal inflammatory mediator CGRP in mice.Exp Neurol,291,62-73.
41. Lin, YT,Liu, TY,Yang, CY,YL,Chen, TC,Day, YJ(2016).Chronic activation of NPFFR2 stimulates the stress-related depressive behaviors through HPA axis modulation.Psychoneuroendocrinology,71,73-85.
42. Lin, YT,Yu, YL,Hong, WC,Yeh, TS,Chen, TC,Chen, JC(2017).NPFFR2 activates the HPA axis and induces anxiogenic effects in rodents.Int J Mol Sci,18,pii: E1810.
43. Liu, Q,Guan, XM,Martin, WJ,McDonald, TP,Clements, MK,Jiang, Q(2001).Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception.J Biol Chem,276,36961-36969.
44. Ma, L,MacTavish, D,Simonin, F,Bourguignon, JJ,Watanabe, T,Jhamandas, JH(2009).Prolactin-releasing peptide effects in the rat brain are mediated through the neuropeptide FF receptor.Eur J Neurosci,30,1585-1593.
45. Mahar, I,Bambico, FR,Mechawar, N,Nobrega, JN(2014).Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects.Neurosci Biobehav Rev,38,173-192.
46. Majane, EA,Panula, P,Yang, HY(1989).Rat brain regional distribution and spinal cord neuronal pathway of FLFQPQRF-NH2, a mammalian FMRF-NH2-like peptide.Brain Res,494,1-12.
47. Mollereau, C,Mazarguil, H,Marcus, D,Quelven, I,Kotani, M,Lannoy, V(2002).Pharmacological characterization of human NPFF (1) and NPFF (2) receptors expressed in CHO cells by using NPY Y (1) receptor antagonists.Eur J Pharmacol,451,245-256.
48. Moulédous, L,Froment, C,Dauvillier, S,Burlet-Schiltz, O,Zajac, JM,Mollereau, C(2012).GRK2 protein-mediated transphosphorylation contributes to loss of function of μ-opioid receptors induced by neuropeptide FF (NPFF2) receptors.J Biol Chem,287,12736-12749.
49. Moulédous, L,Mollereau, C,Zajac, JM(2010).Opioid-modulating properties of the neuropeptide FF system.Biofactors,36,423-429.
50. Nestler, EJ,Barrot, M,DiLeone, RJ,Eisch, AJ,Gold, SJ,Monteggia, LM(2002).Neurobiology of depression.Neuron,34,13-25.
51. Nicklous, DM,Simansky, KJ(2003).Neuropeptide FF exerts pro- and anti-opioid actions in the parabrachial nucleus to modulate food intake.Am J Physiol Regul Integr Comp Physiol,285,R1046-R1054.
52. Perry, SJ,Huang E, Yi-Kung,Cronk, D,Bagust, J,Sharma, R,Walker, RJ(1997).A human gene encoding morphine modulating peptides related to NPFF and FMRFamide.FEBS Lett,409,426-430.
53. Pittenger, C,Duman, RS(2008).Stress, depression, and neuroplasticity: A convergence of mechanisms.Neuropsychopharmacology,33,88-109.
54. Price, DA,Greenberg, MJ(1977).Structure of a molluscan cardioexcitatory neuropeptide.Science,197,670-671.
55. Raffa, RB,Kim, A,Rice, KC,de Costa, BR,Codd, EE,Rothman, RB(1994).Low affinity of FMRFamide and four faRPs (FMRFamide‑related peptides), including the mammalian-derived faRPs F-8-famide (NPFF) and A-18-famide, for opioid mu, delta, kappa 1, kappa 2a, or kappa 2b receptors.Peptides,15,401-404.
56. Rebeyrolles, S,Zajac, JM,Roumy, M(1996).Neuropeptide FF reverses the effect of mu-opioid on ca2+channels in rat spinal ganglion neurones.Neuroreport,7,2979-2981.
57. Riedemann, T,Patchev, AV,Cho, K,Almeida, OF(2010).Corticosteroids: Way upstream.Mol Brain,2,3.
58. Samson, WK,Keown, C,Samson, CK,Samson, HW,Lane, B,Baker, JR(2003).Prolactin-releasing peptide and its homolog RFRP-1 act in hypothalamus but not in anterior pituitary gland to stimulate stress hormone secretion.Endocrine,20,59-66.
59. Schwartz, MW,Woods, SC,Porte, D, Jr.,Seeley, RJ,Baskin, DG.(2000).Central nervous system control of food intake.Nature,404,661-671.
60. Sun, YL,Zhang, XY,He, N,Sun, T,Zhuang, Y,Fang, Q(2012).Neuropeptide FF activates ERK and NF kappa B signal pathways in differentiated SH-SY5Y cells.Peptides,38,110-117.
61. Sun, YL,Zhang, XY,Sun, T,He, N,Li, JY,Zhuang, Y(2013).The anti‑inflammatory potential of neuropeptide FF in vitro and in vivo.Peptides,47,124-132.
62. Sunter, D,Hewson, AK,Lynam, S,Dickson, SL(2001).Intracerebroventricular injection of neuropeptide FF, an opioid modulating neuropeptide, acutely reduces food intake and stimulates water intake in the rat.Neurosci Lett,313,145-148.
63. Tolson, KP,Garcia, C,Yen, S,Simonds, S,Stefanidis, A,Lawrence, A(2014).Impaired kisspeptin signaling decreases metabolism and promotes glucose intolerance and obesity.J Clin Invest,124,3075-3079.
64. Ulrich-Lai, YM,Herman, JP(2009).Neural regulation of endocrine and autonomic stress responses.Nat Rev Neurosci,10,397-409.
65. Vilim, FS,Aarnisalo, AA,Nieminen, ML,Lintunen, M,Karlstedt, K,Kontinen, VK(1999).Gene for pain modulatory neuropeptide NPFF: Induction in spinal cord by noxious stimuli.Mol Pharmacol,55,804-811.
66. Waqas, SF,Hoang, AC,Lin, YT,Ampem, G,Azegrouz, H,Balogh, L(2017).Neuropeptide FF increases M2 activation and self-renewal of adipose tissue macrophages.J Clin Invest,127,2842-2854.
67. Woods, SC,Seeley, RJ,Porte, D, Jr,Schwartz, MW(1998).Signals that regulate food intake and energy homeostasis.Science,280,1378-1383.
68. Yamada, T,Mochiduki, A,Sugimoto, Y,Suzuki, Y,Itoi, K,Inoue, K(2009).Prolactin-releasing peptide regulates the cardiovascular system via corticotrophin-releasing hormone.J Neuroendocrinol,21,586-593.
69. Yang, HY,Fratta, W,Majane, EA,Costa, E(1985).Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine.Proc Natl Acad Sci U S A,82,7757-7761.
70. Yang, HY,Tao, T,Iadarola, MJ(2008).Modulatory role of neuropeptide FF system in nociception and opiate analgesia.Neuropeptides,42,1-18.
71. Yeo, GS,Heisler, LK(2012).Unraveling the brain regulation of appetite: Lessons from genetics.Nat Neurosci,15,1343-1349.
72. Zeng, Z,McDonald, TP,Wang, R,Liu, Q,Austin, CP(2003).Neuropeptide FF receptor 2 (NPFF2) is localized to pain-processing regions in the primate spinal cord and the lower level of the medulla oblongata.J Chem Neuroanat,25,269-278.
73. Zhang, L,Ip, CK,Lee, IJ,Qi, Y,Reed, F,Karl, T(2018).Diet-induced adaptive thermogenesis requires neuropeptide FF receptor-2 signalling.Nat Commun,9,4722.